Sunshine Biopharma (SBFM) Gross Profit (2018 - 2025)
Historic Gross Profit for Sunshine Biopharma (SBFM) over the last 8 years, with Q3 2025 value amounting to $3.1 million.
- Sunshine Biopharma's Gross Profit rose 723.58% to $3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.3 million, marking a year-over-year increase of 2144.05%. This contributed to the annual value of $10.7 million for FY2024, which is 2794.79% up from last year.
- Per Sunshine Biopharma's latest filing, its Gross Profit stood at $3.1 million for Q3 2025, which was up 723.58% from $3.4 million recorded in Q2 2025.
- In the past 5 years, Sunshine Biopharma's Gross Profit registered a high of $3.4 million during Q2 2025, and its lowest value of $21538.0 during Q1 2021.
- In the last 5 years, Sunshine Biopharma's Gross Profit had a median value of $2.0 million in 2023 and averaged $1.6 million.
- In the last 5 years, Sunshine Biopharma's Gross Profit surged by 615761.05% in 2022 and then skyrocketed by 723.58% in 2025.
- Over the past 5 years, Sunshine Biopharma's Gross Profit (Quarter) stood at $23829.0 in 2021, then skyrocketed by 6157.61% to $1.5 million in 2022, then skyrocketed by 72.22% to $2.6 million in 2023, then grew by 20.44% to $3.1 million in 2024, then dropped by 0.63% to $3.1 million in 2025.
- Its Gross Profit stands at $3.1 million for Q3 2025, versus $3.4 million for Q2 2025 and $2.7 million for Q1 2025.